In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 401 for your search:
Cancer Type/Condition:  Stomach (gastric) cancer
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Prevention, Treatment
Status: Active
Age: 30 and over
Sponsor: Other
Protocol IDs: 940110, NCT00155389
2.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000454401, GERCOR-TAUROX, SANOFI-GERCOR-TAUROX, EU-20573, NCT00274885
3.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: Firenze 1, NCT00757640
4.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CAP002, NCT00871273
5.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: AGIM-1, NCT01038154
6.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML25477, NCT01260194
7.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 170/11, NCT01552291
8.

Phase: Phase IV
Type: Diagnostic, Supportive care
Status: Approved-not yet active
Age: 19 to 85
Sponsor: Other
Protocol IDs: GIRBA2681-2012, NCT01579071
9.

Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-221, NCT01653171
10.

Phase: Phase IV
Type: Health services research, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 240293, NCT01698177
11.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 20 to 75
Sponsor: Other
Protocol IDs: MD_SCHBC_IRB_2012-06, NCT01758965
12.

Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 18 to 70
Sponsor: Other
Protocol IDs: EEN-001, NCT01766765
13.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care
Status: Approved-not yet active
Age: 15 to 85
Sponsor: Other
Protocol IDs: Fo-Lap, NCT01819961
14.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000536013, MRC-ST03, EU-20710, ISRCTN46020948, EUDRACT-2006-000811-12, CTA-00316/0221/001, NCT00450203
15.

Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: BREC-AGC, NCT01206218
16.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: FLOT4, NCT01216644
17.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: TOTTG030103, NCT01516944
18.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 30 to 70
Sponsor: Other
Protocol IDs: DongFang, FNSP2009Y0039, NCT01528059
19.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011-004405-25, NCT01683864
20.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: A120566-21, NCT01717924
21.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GC-COMB-0254/275/2012-MUL, GC-0254/282/2011/275/2012-MUL, NCT01787539
22.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Approved-not yet active
Age: Over 18 to 70
Sponsor: Other
Protocol IDs: 91-03-33-18878, NCT01829178
23.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRE-2004.311, NCT00164918
24.

Phase: Phase III
Type: Treatment
Status: Active
Age: 20 to 75
Sponsor: Other
Protocol IDs: JCOG0501, C000000279, NCT00252161
25.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRITICS, NCT00407186
1     
New Search